Search Results

You are looking at 91 - 100 of 551 items for :

  • neuroendocrine cancer x
  • All content x
Clear All
Free access

Jessica L Geiger, Simion I Chiosea, Sue M Challinor, Marina N Nikiforova, and Julie E Bauman

2013 Cabozantinib in progressive medullary thyroid cancer . Journal of Clinical Oncology 31 3639 – 3646 . ( doi:10.1200/JCO.2012.48.4659 ). Farhandi M Taylor J Harvey A O'Dorisio TM 1987 Neuroendocrine (carcinoid) tumor of the lung

Free access

Salvatore Luca Burgio, Vincenza Conteduca, Cecilia Menna, Elisa Carretta, Lorena Rossi, Emanuela Bianchi, Barbara Kopf, Francesca Fabbri, Dino Amadori, and Ugo De Giorgi

us to easily detect and monitor neuroendocrine differentiation in prostate cancer patients ( Berruti et al . 2005 , Sciarra et al . 2009 , Matei et al . 2012 ). In this retrospective study, we evaluated baseline serum CgA levels as a predictor of

Free access

Joanne Y Y Ngeow and Laura S Ward

authors update the use of established as well as novel immune checkpoint inhibitors across the various endocrine-related cancers including less common tumor subtypes such as neuroendocrine cancers and adrenocortical cancers. It is evident from their review

Free access

M Heetfeld, C N Chougnet, I H Olsen, A Rinke, I Borbath, G Crespo, J Barriuso, M Pavel, D O'Toole, T Walter, and other Knowledge Network members

Oberg KE Janson ET Eriksson BK 2001 Treatment with cisplatin and etoposide in patients with neuroendocrine tumors . Cancer 92 1101 – 1107 . ( doi:10.1002/1097-0142(20010901)92:5<1101::AID-CNCR1426>3.0.CO;2-V ). Hadoux J Malka D

Free access

Krystallenia I Alexandraki, Ariadni Spyroglou, Stylianos Kykalos, Kosmas Daskalakis, Georgios Kyriakopoulos, Georgios C Sotiropoulos, Gregory A Kaltsas, and Ashley B Grossman

oncogenic alterations in cancer cells but with increasing recognition of the significance of the tumour microenvironment ( Friedmann-Morvinski & Verma 2014 ). Thus, according to this view, the neuroendocrine tumour develops from mature neuroendocrine cells

Free access

Deborah J Marsh and Charis Eng

:10.1136/bmjopen-2015-009022 ) Pavel ME 2016 WOMEN IN CANCER PROFILE: Neuroendocrine tumors: moving from the land of small tumors to an expanding universe . Endocrine-Related Cancer 23 P23 – P26 . ( doi:10.1530/erc-16-0371 ) Pavel ME

Free access

Halfdan Sorbye, Grace Kong, and Simona Grozinsky-Glasberg

(GEP) neuroendocrine neoplasms (NENs) are uncommon neoplasms accounting for 1.0–1.5% of all digestive cancers. In the new 2019 WHO classification of GEP NEN, the neuroendocrine tumor (NET) category is now used for well-differentiated tumors regardless

Free access

G Rindi, C Klersy, F Inzani, G Fellegara, L Ampollini, A Ardizzoni, N Campanini, P Carbognani, T M De Pas, D Galetta, P L Granone, L Righi, M Rusca, L Spaggiari, M Tiseo, G Viale, M Volante, M Papotti, and G Pelosi

, we competitively tested a large multicenter cohort of lung neuroendocrine tumors with the WHO 2004 classification of lung neuroendocrine cancer (from now on WHO 2004) vs the current WHO classification of digestive neuroendocrine neoplasms (from now on

Free access

Wouter W de Herder, Erik P Krenning, and Gabriel P Krestin

everolimus in gastrointestinal and pancreatic neuroendocrine tumors after 177 Lu-octreotate . Endocrine-Related Cancer 20 825 – 831 . ( doi:10.1530/ERC-13-0254 ) Kwekkeboom DJ Kam BL van Essen M Teunissen JJ van Eijck CH Valkema

Free access

Thomas Cuny, Wouter de Herder, Anne Barlier, and Leo J Hofland

human cancers ( Modlin et al. 2008 , Lawrence et al. 2011 , Hallet et al. 2014 , Dasari et al. 2017 ). Pancreatic neuroendocrine tumors (PNETs) represent around 10% of the neuroendocrine tumors (NETs) seen in the clinic, while the